COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,541 Articles (22,881 medRxiv, 8,660 bioRxiv)

Most recent first Previous |  Page 1561: Articles 15601-15610  | Next

Risk of COVID-19 epidemic resurgence with the introduction of vaccination passes
Krueger, T., Gogolewski, K., Bodych, M., Gambin, A., Giordano, G., Cuschieri, S., Czypionka, T., Perc, M., Petelos, E., Rosinska, M., Szczurek, E.
10.1101/2021.05.07.21256847 — Posted: 2021-05-14
Analysis of 472,688 severe cases of COVID-19 in Brazil showed lower mortality in those vaccinated against influenza
Sardinha, D. M., Lobato, D. d. C., Ferreira, A. L. d. S., Lima, K. V. B., Guimaraes, R. J. d. P. S. e., Lima, L. N. G. C.
10.1101/2021.05.11.21257053 — Posted: 2021-05-14 Discussion: Onsite
Cost-effectiveness of whole area testing of asymptomatic SARS-CoV-2 infections in Merthyr Tydfil, 2020: A Modelling and economic analysis
Drakesmith, M., Collins, B., Nnoaham, K., Jones, A., Thomas, D. R.
10.1101/2021.05.10.21256816 — Posted: 2021-05-14
Longer incubation periods of SARS-CoV-2 infection in infants
Leung, C.
10.1101/2021.05.07.21256798 — Posted: 2021-05-14
A linear Mixed Model to Estimate COVID-19-induced Excess Mortality
Verbeeck, J., Faes, C., Neyens, T., Hens, N., Verbeke, G., Deboosere, P., Molenberghs, G.
10.1101/2021.05.10.21256942 — Posted: 2021-05-14
In hospital cardiac arrest in Intensive Care Unit versus non Intensive Care Unit patients with COVID 19. A systematic review and meta analysis
Mavrovounis, G., Mermiri, M., Chalkias, A., Sheth, V., Tsolaki, V., Gourgoulianis, K., Pantazopoulos, I.
10.1101/2021.05.08.21256885 — Posted: 2021-05-14
Evolution of human antibody responses up to one year after SARS-CoV-2 infection
Gallais, F., Gantner, P., Bruel, T., Velay, A., Planas, D., Wendling, M.-J., Bayer, S., Solis, M., Laugel, E., Reix, N., Schneider, A., Glady, L., Panaget, B., Collongues, N., Partisani, M., Lessinger, J.-M., Fontanet, A., Rey, D., Hansmann, Y., Kling-Pillitteri, L., Schwartz, O., De Seze, J., Meyer, N., Gonzalez, M., Schmidt-Mutter, C., Fafi-Kremer, S.
10.1101/2021.05.07.21256823 — Posted: 2021-05-14
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
Shroff, R. T., Chalasani, P., Wei, R., Pennington, D., Quirk, G., Schoenle, M. V., Uhrlaub, J. L., Ripperger, T. J., Jergovic, M., Dalgai, S., Wolf, A., Hammad, H., Carrier, A., Scott, A. J., Nikolich-Zugich, J., Worobey, M., Sprissler, R., Dake, M. D., LaFleur, B. J., Bhattacharya, D.
10.1101/2021.05.13.21257129 — Posted: 2021-05-14 Discussion: Onsite
Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review
Malik, J., Zaidi, S. M. J., Ishaq, U., Ali, M., Rana, A. S., Iqbal, R., Waqar, A. U., Kashif, M.
10.1101/2021.05.09.21256911 — Posted: 2021-05-14
Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variant
Knabl, L., Lee, H. K., Wieser, M., Mur, A., Zabernigg, A., Knabl, L., Rauch, S., Bock, M., Schumacher, J., Kaiser, N., Furth, P. A., Hennighausen, L.
10.1101/2021.05.11.21256862 — Posted: 2021-05-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).